There is no single LDL number that triggers a statin prescription for everyone. The clearest threshold is 190 mg/dL or higher, where guidelines recommend a statin regardless of other risk factors. Below that, the decision depends on whether you have diabetes, existing heart disease, or enough additional risk factors to tip the balance. Here’s how those categories break down.
LDL of 190 or Higher: Statins Recommended
An LDL of 190 mg/dL or above is classified as severe hypercholesterolemia. At this level, the ACC/AHA guidelines call for the highest tolerated statin dose as a first-line treatment, with no need for further risk calculation. This applies to adults of any age, including those in their 20s and 30s, because the cumulative exposure to high LDL over a lifetime dramatically raises the odds of heart attack and stroke. Starting treatment earlier in life, when LDL has been severely elevated for fewer years, may actually have the greatest impact on preventing premature cardiovascular disease.
People with LDL in this range often have a genetic component, sometimes familial hypercholesterolemia, and lifestyle changes alone rarely bring levels down enough. A high-intensity statin, which lowers LDL by 50% or more, is the standard starting point.
LDL of 70 to 189: Risk Factors Decide
For most adults aged 40 to 75 with LDL between 70 and 189 mg/dL, the statin conversation starts with estimating your 10-year risk of a cardiovascular event using a tool called the Pooled Cohort Equations. Your doctor plugs in your age, sex, race, blood pressure, cholesterol numbers, smoking status, and diabetes status to generate a percentage. That percentage places you into one of several risk tiers, and each tier has different implications for treatment.
If your 10-year risk is borderline (5% to 7.5%) or intermediate (7.5% to 20%), the decision isn’t automatic. This is where “risk-enhancing factors” come in. These are conditions or markers that suggest your actual risk is higher than the calculator predicts:
- Family history of early heart disease (before age 55 in a father or brother, before 65 in a mother or sister)
- Chronic inflammatory conditions like rheumatoid arthritis, lupus, or psoriasis
- Metabolic syndrome (a cluster of high blood pressure, high blood sugar, excess belly fat, and abnormal cholesterol)
- Chronic kidney disease
- South Asian ancestry
- Elevated triglycerides persistently at or above 175 mg/dL
- Elevated lipoprotein(a) at or above 50 mg/dL
- For women: history of preeclampsia or early menopause (before age 40)
If you have one or more of these factors, your doctor is more likely to recommend starting a statin even if your LDL isn’t dramatically high. An LDL between 160 and 189 mg/dL is itself considered a risk-enhancing factor because of the elevated lifetime exposure to cholesterol.
Diabetes Changes the Equation
If you have diabetes and you’re between 40 and 75, current guidelines recommend at least a moderate-intensity statin regardless of your LDL level. Diabetes independently raises cardiovascular risk enough that most adults with the condition qualify for treatment. The statin intensity, moderate or high, depends on your overall risk profile and whether you have additional risk-enhancing factors on top of diabetes.
Existing Heart Disease: No LDL Minimum
If you’ve already had a heart attack, stroke, or have documented plaque buildup in your arteries, a statin is recommended regardless of your LDL level at the time. This is called secondary prevention, and the goal shifts from “should we start treatment” to “how low can we get your LDL.” European Society of Cardiology guidelines set the target below 55 mg/dL for people with established cardiovascular disease, with at least a 50% reduction from your starting level. For people who have a second cardiovascular event within two years, the target drops even further to below 40 mg/dL.
In cases of acute events like a heart attack, a high-intensity statin is typically started during the hospital stay itself, as early as possible, to reduce risk during the period of greatest vulnerability and to build the habit before discharge.
Adults Over 75
Statin decisions for adults over 75 are less clear-cut because clinical trial data in this age group is limited. The 2018 AHA/ACC guidelines state it’s “reasonable to consider” starting a moderate-intensity statin for those over 75 with LDL between 70 and 189 mg/dL. Most adults in this age range automatically reach high-risk thresholds simply because of age, so the conversation centers more on life expectancy, other medications, and personal preference than on hitting a specific LDL number. For those already taking a statin, continuing it is generally better supported by evidence than stopping.
Moderate vs. High-Intensity Statins
When your doctor recommends a statin, they’ll choose an intensity level based on how much your LDL needs to drop. Moderate-intensity therapy typically lowers LDL by 30% to 49%. High-intensity therapy aims for a 50% reduction or greater. The intensity is determined by the specific drug and dose, not by taking more pills.
High-intensity statins are the standard for anyone with LDL at or above 190, anyone with established heart disease, and higher-risk patients with diabetes. Moderate-intensity statins are more commonly used for primary prevention in people at intermediate risk or those with diabetes who don’t have additional high-risk features.
What Happens After You Start
Once you begin a statin, your doctor will typically recheck your lipid panel 6 to 8 weeks after starting or adjusting the dose. This first follow-up confirms the medication is working and helps determine whether the intensity needs to change. After that, lipid panels are usually repeated every 4 to 6 months. Liver function tests are checked at baseline, around 12 weeks, and then annually. If you develop unexplained muscle soreness or weakness, your doctor may check a muscle enzyme called creatine kinase to rule out a rare but real side effect.
The goal isn’t just to see your LDL drop on paper. It’s to confirm you’re reaching the percentage reduction or absolute target that matches your risk category, and to make sure you’re tolerating the medication well enough to stay on it long-term.